BiVictriX Therapeutics (BVX) Stock Chart & Stock Price History → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free BVX Stock Alerts GBX 11.50 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades BiVictriX Therapeutics Stock Price Performance5 Day Performance0.00%1 Month Performance-0.35%3 Month PerformanceN/A6 Month Performance-4.17%Year-To-Date PerformanceN/A1 Year Performance-23.08% Receive BVX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BiVictriX Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 Media“Dollar Will Be Worth NOTHING” -MuskElon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.Click here to claim your free seat ticket now. BVX Stock Chart for Friday, May, 17, 2024 BVX Chart by TradingView BiVictriX Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024GBX 11.50GBX 11.50GBX 11.50GBX 10.5010,000 shs£9.49 million05/16/2024GBX 11.50GBX 11.50GBX 11.50GBX 10.5010,000 shs£9.49 million05/15/2024GBX 10.50GBX 11.50+9.52%GBX 11.50GBX 10.5010,000 shs£9.49 million05/14/2024GBX 11.50GBX 10.50-8.70%GBX 10.50GBX 10.5010,000 shs£8.67 million05/10/2024GBX 11.50GBX 11.50GBX 11.50GBX 118,000 shs£9.49 million05/09/2024GBX 11.50GBX 11.50GBX 11.50GBX 118,000 shs£9.49 million Get the Latest News and Ratings for BVX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BiVictriX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024GBX 12GBX 12GBX 12GBX 11161 shs£9.90 million05/06/2024GBX 11.50GBX 12+4.35%GBX 12GBX 11161 shs£9.90 million05/03/2024GBX 12GBX 11.50-4.17%GBX 12GBX 11161 shs£9.49 million05/02/2024GBX 12GBX 12GBX 12GBX 1110 shs£9.90 million05/01/2024GBX 11.50GBX 12+4.35%GBX 12GBX 1222 shs£9.90 million04/26/2024GBX 11.50GBX 11.50GBX 11.68GBX 11.50428 shs£9.49 million04/25/2024GBX 11.50GBX 11.50GBX 11.68GBX 11.50428 shs£9.49 million04/24/2024GBX 11.50GBX 11.50GBX 11.68GBX 11.50428 shs£9.49 million04/23/2024GBX 11.50GBX 11.50GBX 11.68GBX 11.50428 shs£9.49 million04/22/2024GBX 11.50GBX 11.50GBX 11.68GBX 11.50428 shs£9.49 million04/19/2024GBX 11GBX 11.50+4.55%GBX 11.50GBX 11188,757 shs£9.49 million04/18/2024GBX 11.54GBX 11-4.68%GBX 11.03GBX 11188,757 shs£9.08 million04/17/2024GBX 11.25GBX 11.54+2.58%GBX 11.54GBX 11.5420,000 shs£9.52 million04/16/2024GBX 10.52GBX 11.25+6.99%GBX 11.25GBX 11.252,021 shs£9.29 million04/15/2024GBX 11.25GBX 10.52-6.53%GBX 11.25GBX 10.522,021 shs£8.68 million04/12/2024GBX 11.25GBX 10.52-6.53%GBX 10.52GBX 10.522,023 shs£8.68 million04/10/2024GBX 11.25GBX 11.25GBX 11.25GBX 11.2510,000 shs£9.29 million04/09/2024GBX 10.51GBX 11.25+7.04%GBX 11.25GBX 10.5110,000 shs£9.29 million04/08/2024GBX 10.51GBX 10.51GBX 11.25GBX 10.5110,000 shs£8.67 million04/05/2024GBX 11.87GBX 10.51-11.46%GBX 10.51GBX 10.5110,000 shs£8.67 million04/04/2024GBX 11.50GBX 11.87+3.22%GBX 11.90GBX 10.50198,003 shs£9.80 million04/03/2024GBX 11.25GBX 11.50+2.22%GBX 11.50GBX 11.5025,983 shs£9.49 million04/01/2024GBX 11.25GBX 11.25GBX 11.55GBX 10.5014,569 shs£9.29 million03/29/2024GBX 11.25GBX 11.25GBX 11.55GBX 10.5014,569 shs£9.29 million03/28/2024GBX 11.75GBX 11.25-4.26%GBX 11.55GBX 10.5014,569 shs£9.29 million03/27/2024GBX 11.75GBX 11.75GBX 11.75GBX 11.759,000 shs£9.70 million03/26/2024GBX 11.75GBX 11.75GBX 11.75GBX 11.609,000 shs£9.70 million03/25/2024GBX 11.75GBX 11.75GBX 11.75GBX 11.609,000 shs£9.70 million03/22/2024GBX 12GBX 11.51-4.12%GBX 11.51GBX 11.5110,000 shs£9.50 million03/21/2024GBX 11.75GBX 12+2.13%GBX 12GBX 11.50253 shs£9.90 million03/20/2024GBX 11.55GBX 11.75+1.73%GBX 11.75GBX 11.555,000 shs£9.70 million03/19/2024GBX 11.87GBX 11.55-2.70%GBX 11.55GBX 11.555,000 shs£9.53 million03/18/2024GBX 11.87GBX 11.87GBX 11.87GBX 11.75750 shs£9.80 million03/15/2024GBX 11.75GBX 11.87+1.02%GBX 11.87GBX 11.87752 shs£9.80 millionA ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now.03/12/2024GBX 11.50GBX 11.75+2.17%GBX 11.75GBX 11.75100 shs£9.70 million03/11/2024GBX 11.75GBX 11.50-2.13%GBX 11.75GBX 11.50100 shs£9.49 million03/08/2024GBX 11.50GBX 11.75+2.17%GBX 11.87GBX 11.5018,134 shs£9.70 million03/07/2024GBX 11.60GBX 11.50-0.86%GBX 11.50GBX 11.509 shs£9.49 million03/06/2024GBX 11.75GBX 11.60-1.28%GBX 11.87GBX 11.5018,134 shs£9.57 million03/05/2024GBX 11.50GBX 11.75+2.17%GBX 11.75GBX 11.5981,065 shs£9.70 million03/04/2024GBX 11.50GBX 11.50GBX 11.50GBX 11.05789 shs£9.49 million03/01/2024GBX 11.50GBX 11.50GBX 11.50GBX 11.50789 shs£9.49 million02/29/2024GBX 11.05GBX 11.50+4.07%GBX 11.50GBX 11.05789 shs£9.49 million02/28/2024GBX 11.50GBX 11.05-3.91%GBX 11.05GBX 11.05789 shs£9.12 million Related Companies: ImmuPharma Stock Chart Genflow Biosciences Stock Chart Synairgen Stock Chart Roquefort Therapeutics Stock Chart BSF Enterprise Stock Chart ValiRx Stock Chart Destiny Pharma Stock Chart Aptamer Group Stock Chart NetScientific Stock Chart IXICO Stock Chart Receive BVX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BiVictriX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:BVX) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA ‘DeFi Summer’ Projected!Crypto 101 MediaUrgent Nvidia WarningAltimetryBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiVictriX Therapeutics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.